Skip to content

Author

S. Jyothi

We have 5 of 97 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

The therapeutic effects and mechanisms of action of baicalin in sepsis: a systematic review.

Sepsis is a critical medical state considered a life-threatening response to infection, leading to extensive inflammation and potential organ dysfunction. This systematic review focuses on the therapeutic impact of baicalin on sepsis complications. METHODS This systematic review followed PRISMA guidelines and was reg...

Usamah Sayed, Naji Musa Ali, S. Jyothi et al. · 0 citations
Review Open access Sep 2026

Targeting the Immunosuppressive Microenvironment in Colorectal Cancer: Pharmacological and Nanomedicine Strategies

The fundamental immunosuppressive interactions within the TME are discussed and subsequently it is examined how these agents enhance immune responses by reprogramming stromal and immune cells, as well as their secreted mediators within the TIME.

Qamar Abuhassan, Usamah Sayed, Pareshkumar N. Patel et al. · 0 citations
Aug 2026

Nanomedicine for biofilm associated infections: opportunities, challenges, and clinical translation

Comparative studies suggest that combination approaches, including enzyme functionalized or stimuli responsive nanoparticles paired with antibiotics, may outperform single modality treatments by simultaneously disrupting the biofilm matrix and delivering active agents.

Husni Farah, Munthar Kadhim-Abosaoda, Hayjaa Mohaisen-Mousa et al. · 0 citations
Review Open access Aug 2026

Tumor‐Associated Macrophages in the Chemoresistant Microenvironment of Gastric Cancer: Key Mechanisms and Intercellular Crosstalk

Current evidence on TAM‐driven chemoresistance in GC is synthesized, highlighting the molecular interplay between TAMs, tumor cells, and stromal components and underscores the potential of TAM‐centric therapies to overcome resistance and improve clinical outcomes.

S. Abdul-Rahman, Abdulkareem Shareef, S. Jyothi et al. · 0 citations
Review 2026

AI-driven CRISPR strategies in breast cancer: Organoid modeling, adaptive editing, and precision delivery

The strategies detailed here define a next-generation precision-oncology paradigm capable of anticipating tumor evolution, overcoming resistance, and preventing metastatic relapse, by uniting AI-guided design, circadian reprogramming, dormancy eradication, and logic-gated delivery.

Anmar Ghanim Taki, Abdulkareem Shareef, Vimal Arora et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.